agilon health, inc. CTO to Depart; Severance and Consulting Agreement

What Happened
agilon health, inc. filed an 8‑K (Item 5.02) reporting that Chief Technology Officer Girish Venkatachaliah was notified on July 17, 2026 that his employment will terminate effective August 1, 2026. The company provided a Severance Agreement and General Release and plans a Consulting Agreement effective August 1, 2026 for transition services through December 31, 2026. The severance package includes a cash payment of $766,063 and continued equity vesting through April 30, 2027 for certain awards.

Key Details

• Separation effective date: August 1, 2026; notice given July 17, 2026.
• Cash severance: $766,063, payable in installments over 12 months after the Separation Date.
• Equity treatment: continued vesting through April 30, 2027 for the 2025 transformation equity award and other time/service‑vesting RSUs scheduled to vest on or before that date (subject to any performance vesting conditions).
• Consulting arrangement: transition consulting from Aug 1–Dec 31, 2026 with no cash compensation (consulting consideration is the continued equity vesting described above). The Severance Agreement becomes effective eight days after the executive signs it.

Why It Matters
This 8‑K documents a leadership change in agilon’s technology function and lays out the company’s cash and equity commitments tied to that departure. For investors, the material points are the one‑time cash obligation of $766,063 (paid over a year) and the decision to continue equity vesting through April 30, 2027, which affects compensation expense and share‑based dilution timing. The consulting period provides a defined transition window through year‑end 2026 without additional cash pay, which may limit ongoing cash outflow beyond the severance installments.